Luteoloside Ameliorates Palmitic Acid-Induced <i>in Vitro</i> Model of Non-alcoholic Fatty Liver Disease via Activating STAT3-Triggered Hepatocyte Regeneration Cited by

Fol. Biol. 2021, 67, 126-133

https://doi.org/10.14712/fb2021067030126

Luteoloside Ameliorates Palmitic Acid-Induced in Vitro Model of Non-alcoholic Fatty Liver Disease via Activating STAT3-Triggered Hepatocyte Regeneration

Y. X. Zhu¹, L. Zhu¹, Y. F. Chen¹, J. M. Xu¹, Z. L. Shen¹, R. J. Liu¹, J. Zou¹, Mingqing Yuan¹, Fan Ye¹, Qingqi Zeng²

¹Department of Pharmacy, Affiliated Kunshan Hospital of Jiangsu University, Kunshan 215300, Jiangshu, China
²Jiangsu Health Vocational College; Nanjing 210023, China

Received May 2021
Accepted September 2021

Crossref Cited-by Linking

Xiu Mengxue, Zhao Yiming, Wang Xuehui, Yuan Siyu, Qin Bofeng, Sun Jinghui, Cui Long, Song Jian: Regulation of SIRT1-TLR2/TLR4 pathway in cell communication from macrophages to hepatic stellate cells contribute to alleviates hepatic fibrosis by Luteoloside. Acta Histochemica 2023, 125, 151989. <https://doi.org/10.1016/j.acthis.2022.151989>
Wang Lu, Yan Yonghuan, Wu Linfang, Peng Jinyong: Natural products in non-alcoholic fatty liver disease (NAFLD): Novel lead discovery for drug development. Pharmacological Research 2023, 196, 106925. <https://doi.org/10.1016/j.phrs.2023.106925>